Sort   by:  
 Page size 
UnknownBACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1.
Not available
S-EPMC9205595 | biostudies-literature
TranscriptomicsAXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.
Phosphoinositide-3-kinase (PI3K)-α inhibitors are clinically active in squamous carcinoma (SCC) of the head and neck (H&N) bearing mutations or amplification of PIK3CA. We aimed to identify potential mechanism of resistance and have observed that SCCs cells overcome the antitumor effects of the PI3K...
ORGANISM(S): Homo sapiens 
2015-04-12 | E-GEOD-61515 | biostudies-arrayexpress
UnknownCombating a Global Threat to a Clonal Crop: Banana Black Sigatoka Pathogen Pseudocercospora fijiensis (Synonym Mycosphaerella fijiensis) Genomes Reveal Clues for Disease Control.
Not available
S-EPMC4981457 | biostudies-literature
UnknownMusculoskeletal manifestations in children with Behcet's syndrome: data from the AIDA Network Behcet's Syndrome Registry.
Not available
S-EPMC10082129 | biostudies-literature
UnknownA cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer.
Not available
S-EPMC7597028 | biostudies-literature
UnknownA patient-driven registry on Behcet's disease: the AIDA for patients pilot project.
Not available
S-EPMC10313381 | biostudies-literature
UnknownLong-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Not available
S-EPMC11371380 | biostudies-literature
UnknownThe Risk of Developing Ocular Involvement Among Behcet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behcet's Disease Registry.
Not available
S-EPMC12882929 | biostudies-literature
TranscriptomicsICGC Pancreas: Genomic analysis reveals roles for chromatin modification and axonguidance in pancreatic cancer
Pancreatic cancer (PC) is the fourth leading cause of cancer death with an overall 5-year survival rate of < 5%, a statistic that has changed little in almost 50 years. A deeper understanding of the underlying molecular pathophysiology is expected to advance the urgent need to develop novel therapeu...
ORGANISM(S): Homo sapiens 
2012-03-30 | E-GEOD-36924 | biostudies-arrayexpress
UnknownResuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS.
Not available
S-EPMC8275089 | biostudies-literature
Sort   by:  
 Page size